This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Trident® Tritanium™ Acetabular Shell Revision Study

Sponsored by Stryker Orthopaedics

About this trial

Last updated 8 years ago

Study ID

61

Status

Completed

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
21 to 85 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 9 years ago

What is this trial about?

The purpose of this study is to evaluate a hip implant system used when a previous hip replacement surgery has failed.

What are the participation requirements?

Yes

Inclusion Criteria

1. Males and non-pregnant females, 21-85 years of age at the time of surgery.

2. Patient is a candidate for a revision of a failed acetabular component with a cementless acetabular component.

3. Patient has signed an IRB approved study consent form.

4. Patient is willing and able to comply with postoperative requirements including postoperative weight bearing restrictions and self-evaluations.

No

Exclusion Criteria

1. Patient is morbidly obese, BMI > 40.

2. Patient has a systemic or metabolic bone disorder leading to progressive bone deterioration.

3. Patient is immunologically compromised or receiving steroids in excess of normal physiological requirements (> 30 days).

4. Patient's bone stock is compromised by disease or infection which cannot provide adequate support and/or fixation to the prosthesis.

5. Patient has an active or suspected latent infection on or about the hip joint.

6. Patient is a prisoner.

Locations

Location

Status